Estimaciones de analistas de Wall Street para Marker Therapeutics, Inc. (MRKR): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 1 |
| Compra | 2 |
| Mantener | 2 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 5 |
| Calificación media (1-5) | 0.80 |
Ratios de valoración
| Precio / Valor contable | 1.56 |
| EV / EBITDA | -0.54 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | $183064 | $205994 | $213194 | $466785 | $1.2M | $3.5M | $3.3M | $6.6M | 0 |
| Coste de Ventas | 0 | $5.3M | $124.0M | $12.8M | $18.9M | $3.2M | $12.0M | $10.4M | $13.5M | 0 |
| Beneficio Bruto | 0 | -$5.1M | -$123.8M | -$12.6M | -$18.4M | -$1.9M | -$8.5M | -$7.1M | -$6.9M | 0 |
| I+D | $3.8M | $5.3M | $124.0M | $12.8M | $18.9M | $27.8M | $12.0M | $10.4M | $13.5M | $11.8M |
| Generales y Administrativos | $4.7M | $6.4M | $24.4M | $10.0M | $10.5M | $9.8M | $11.3M | $7.5M | $4.2M | $4.2M |
| Gastos Operativos | $8.3M | $6.4M | $148.4M | $10.0M | $10.5M | $37.6M | $11.3M | $7.5M | $4.2M | $12.9M |
| Beneficio Operativo | -$8.5M | -$11.5M | -$148.2M | -$22.5M | -$28.9M | -$39.5M | -$19.8M | -$14.6M | -$11.1M | -$12.9M |
| EBITDA | $6.0M | -$11.3M | -$148.0M | -$22.4M | -$27.6M | -$38.7M | -$17.0M | -$11.3M | -$10.7M | -$12.4M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$2.5M | -$11.0M | -$148.0M | -$21.4M | -$28.7M | -$41.9M | -$19.8M | -$14.0M | -$10.7M | -$12.2M |
| Impuestos | 0 | 0 | -$214000 | 0 | 0 | 0 | 0 | $3675 | $49953 | -$15156 |
| Beneficio Neto | -$2.5M | -$11.0M | -$148.0M | -$21.4M | -$28.7M | -$41.9M | -$29.9M | -$8.2M | -$10.7M | -$12.2M |
| BPA | $-3.56 | $-11.62 | $-77.50 | $-4.70 | $-6.10 | $-5.47 | $-3.58 | $-1.93 | $-1.19 | $-0.79 |
| BPA Diluido | $-3.31 | $-11.62 | $-77.50 | $-4.70 | $-6.10 | $-5.47 | $-3.58 | $-1.93 | $-1.19 | $-0.79 |
| Acciones en Circulación (Diluidas) | $7.4M | $945348 | $1.9M | $4.6M | $4.7M | $7.7M | $8.4M | $8.8M | $9.0M | $15.3M |
Precio
| Precio | $1.14 |
| Capitalización | $19M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: AEON · BOLT · CLRB · COCP · EVGN · GLTO · IMNN
Explorar sector: Healthcare · Biotechnology
Más secciones de MRKR: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones